Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,302 papers from all fields of science
Search
Sign In
Create Free Account
Meniere Disease
Known as:
Meniere's Syndrome
, Ménière Disease
, Disease, Ménière's
Expand
A disease of the inner ear (LABYRINTH) that is characterized by fluctuating SENSORINEURAL HEARING LOSS; TINNITUS; episodic VERTIGO; and aural…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
21 relations
Narrower (2)
Active Ménière's disease, cochleovestibular
Ménière's Vertigo
Autosomal dominant inheritance
Ear Diseases
Endolymphatic Hydrops
Hearing Disorders and Deafness
Expand
Broader (2)
Labyrinthine disorder
Syndrome
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Extended phenotype and clinical subgroups in unilateral Meniere disease: A cross‐sectional study with cluster analysis
L. Frejo
,
Eduardo Martin-Sanz
,
+17 authors
J. A. Lopez-Escamez
Clinical Otolaryngology
2017
Corpus ID: 31106454
To define clinical subgroups by cluster analysis in patients with unilateral Meniere disease (MD) and to compare them with the…
Expand
Highly Cited
2016
Highly Cited
2016
Clinical Subgroups in Bilateral Meniere Disease
L. Frejo
,
A. Soto-Varela
,
+15 authors
J. Lopez-Escamez
Frontiers in Neurology
2016
Corpus ID: 12920452
Meniere disease (MD) is a heterogeneous clinical condition characterized by sensorineural hearing loss, episodic vestibular…
Expand
Highly Cited
2012
Highly Cited
2012
Intratympanic Treatment of Intractable Unilateral Ménière Disease
A. Casani
,
P. Piaggi
,
N. Cerchiai
,
V. Seccia
,
S. Sellari Franceschini
,
I. Dallan
Otolaryngology Head & Neck Surgery
2012
Corpus ID: 29309285
Objective. To determine the efficacy and safety of low-dose intratympanic gentamicin (ITG) compared with intratympanic…
Expand
Highly Cited
2003
Highly Cited
2003
Intratympanic Gentamicin for Intractable Meniere's Disease
N. Pérez
,
E. Martín
,
R. García‐Tapia
The Laryngoscope
2003
Corpus ID: 24159159
Objective The study aimed to analyze the results of the intratympanic injection of gentamicin as a treatment option for patients…
Expand
Review
2001
Review
2001
Diagnostic value of prolonged latencies in the vestibular evoked myogenic potential.
T. Murofushi
,
Ken Shimizu
,
H. Takegoshi
,
P. Cheng
Archives of Otolaryngology - Head and Neck…
2001
Corpus ID: 5788889
BACKGROUND As a parameter for the evaluation of the vestibular evoked myogenic potential (VEMP), amplitude has been used…
Expand
Highly Cited
2000
Highly Cited
2000
Intractable Benign Paroxysmal Positional Vertigo in Patients With Meniere's Disease
E. Gross
,
B. Ress
,
E. Viirre
,
J. Nelson
,
J. Harris
The Laryngoscope
2000
Corpus ID: 29372362
Objective To provide a detailed description of the coexistence of benign paroxysmal positional vertigo (BPPV) and Meniere's…
Expand
Review
1999
Review
1999
Prevalence of meniere disease in finland
J. Kotimäki
,
M. Sorri
,
E. Aantaa
,
J. Nuutinen
The Laryngoscope
1999
Corpus ID: 21922788
Objectives: To assess the prevalence of Meniere disease in the population of 5 million in Finland according to the criteria of…
Expand
Highly Cited
1981
Highly Cited
1981
The summating potential and Meniere's disease. I. Summating potential amplitude in Meniere and non-Meniere ears.
A. Coats
A M A Archives of Otolaryngology
1981
Corpus ID: 31024238
We investigated the relationship between Meniere's disease and the abnormally enlarged summating potential (SP) in a series of…
Expand
Highly Cited
1974
Highly Cited
1974
The vestibular aqueduct in patients with Menière's disease. A tomographic and clinical investigation.
J. Stahle
,
H. Wilbrand
Acta Oto-Laryngologica
1974
Corpus ID: 34810127
The vestibular aqueduct was identified on tomograms in all healthy subjects. In patients with severe Meniere's disease the…
Expand
Highly Cited
1966
Highly Cited
1966
Glycerol test in Ménière's disease.
I. Klockhoff
,
U. Lindblom
Acta Oto-Laryngologica
1966
Corpus ID: 35576941
Ingestion of glycerol, 1.5 g/kg body weight, causes a transient reduction of the hearing loss in the early stage of Meniere's…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE